A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
出版年份 2017 全文链接
标题
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
作者
关键词
Osteoblasts, Osteoclasts, Cytokines, Bone marrow cells, Osteoblast differentiation, Macrophages, Immunoblotting, Cell signaling
出版物
PLoS One
Volume 12, Issue 7, Pages e0181126
出版商
Public Library of Science (PLoS)
发表日期
2017-07-15
DOI
10.1371/journal.pone.0181126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone
- (2015) Rachelle W. Johnson et al. BONE
- Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts
- (2014) Natalie A. Sims et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- JAK2-STAT3 Blockade by AG490 Suppresses Autoimmune Arthritis in Mice via Reciprocal Regulation of Regulatory T Cells and Th17 Cells
- (2014) J.-S. Park et al. JOURNAL OF IMMUNOLOGY
- AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis
- (2013) Chang-hong Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation
- (2013) Rachelle W Johnson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production
- (2012) Timothy P. LaBranche et al. ARTHRITIS AND RHEUMATISM
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- The Role of Jak/STAT Pathways in Osteoclast Differentiation
- (2011) Young-Kyun Lee et al. Biomolecules & Therapeutics
- GP130 cytokines and bone remodelling in health and disease
- (2011) Natalie A. Sims et al. BMB Reports
- IL-1 and TNF -initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis
- (2011) T. Mori et al. INTERNATIONAL IMMUNOLOGY
- Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization
- (2011) Ingrid J Poulton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
- (2010) Emma C. Walker et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
- (2008) Emma C Walker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
- (2008) Aline Bozec et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started